会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Carbapenem derivatives
    • 卡巴培南衍生物
    • US06310056B1
    • 2001-10-30
    • US09355272
    • 1999-07-28
    • Yuko KanoKazuhiro AiharaYumiko ToyookaToshiro SasakiHiromasa TakizawaKenichi FushiharaKazuko KobayashiKunio AtsumiKatsuyoshi IwamatsuTakashi Ida
    • Yuko KanoKazuhiro AiharaYumiko ToyookaToshiro SasakiHiromasa TakizawaKenichi FushiharaKazuko KobayashiKunio AtsumiKatsuyoshi IwamatsuTakashi Ida
    • A61K31429
    • C07D519/00
    • The carbapenem derivatives represented by the following formula (I) is disclosed. These compounds have strong anti-bacterial activities against bacteria including methicillin resistant Staphylococcus aureus, penicillin resistant Streptococcus pneumoniae, Enterococci, influenza, and &bgr;-lactamase producing bacteria, and have high stabilities to DHP-1 wherein R1 represents hydrogen or methyl, either one of R2, R3, R4, or R5 represents the bond to the 2-position on the carbapenem ring, and the remaining three respectively represent hydrogen, halogen, nitro, cyano, alkyl, cycloalkyl, alkylthio, alkenyl, formyl, alkylcarbonyl, alkoxycarbonyl, aminosulfonyl, aryl carbonyl, aryl, carbamoyl, N-lower alkylcarbamoyl, N,N-di-lower alkylaminocarbonyl, lower alkoxyiminomethyl, or hydroxyiminomethyl, R6 is not present or represents alkyl, cycloalkyl, or alkenyl, and R is not present, or represents hydrogen or a group which may be metabolically hydrolyzed in the body, provided that when R6 is not present, R represents hydrogen or a group which may be metabolically hydrolyzed in the body, and when R6 is present, R is not present, and the compound forms an inner salt.
    • 公开了由下式(I)表示的碳青霉烯衍生物。 这些化合物对包括耐甲氧西林金黄色葡萄球菌,青霉素耐药性肺炎链球菌,肠球菌,流感和β-内酰胺酶生产细菌在内的细菌具有很强的抗细菌活性,并且对于DHP-1具有高稳定性,其中R 1表示氢或甲基,R 2 ,R 3,R 4或R 5表示碳青霉烯环上2-位的键,其余3个分别表示氢,卤素,硝基,氰基,烷基,环烷基,烷硫基,烯基,甲酰基,烷基羰基,烷氧基羰基,氨基磺酰基, 芳基羰基,芳基,氨基甲酰基,N-低级烷基氨基甲酰基,N,N-二低级烷基氨基羰基,低级烷氧基亚氨基甲基或羟基亚氨基甲基,R6不存在或表示烷基,环烷基或烯基,R不存在,或表示氢或 可以在体内代谢水解的基团,条件是当R 6不存在时,R代表氢或可以代谢地水解的基团 e体,当R 6存在时,R不存在,且该化合物形成内盐。
    • 10. 发明授权
    • Cephem derivatives
    • Cephem衍生物
    • US5883089A
    • 1999-03-16
    • US750945
    • 1997-03-12
    • Eijiro UmemuraKunio AtsumiKatsuyoshi IwamatsuAtsushi Tamura
    • Eijiro UmemuraKunio AtsumiKatsuyoshi IwamatsuAtsushi Tamura
    • A61K31/545A61P31/04C07D501/00C07D501/56C07D519/06
    • C07D501/00Y02P20/55
    • Compounds, represented by the following formula (I), having a .beta.-(substituted or unsubstituted imidazo�5,1-b!thiazolyl)vinyl group at the 3-position of the cephem ring and a salt and an ester thereof are disclosed. The compounds have antibacterial activity against a very wide spectrum of bacteria and potent antibacterial activity against Gram-positive bacteria, Gram-negative bacteria, and resistant bacteria. ##STR1## wherein X represents CH or N, R.sup.1 represents a hydrogen atom or an amino protective group, R.sup.2 represents a hydrogen atom, a C.sub.1-6 alkyl group, a C.sub.3-7 cycloalkyl group, or a hydroxy protective group, R.sup.3 is absent or represents a hydrogen atom, a salt forming cation, or a carboxyl protective group, R.sup.4, R.sup.5, and R.sup.6, which may be the same or different, each independently represent a hydrogen atom or a C.sub.1-6 alkyl group, R.sup.7+ is absent or a cation of a C.sub.1-6 alkyl, and n is an integer of 0 to 1.
    • PCT No.PCT / JP96 / 01406 Sec。 371日期1997年4月3日 102(e)日期1997年4月3日PCT提交1996年5月24日PCT公布。 WO94 / 37499 PCT公开号 日期:1996年11月28日由以下式(I)表示的化合物在头孢烯环的3位具有β - (取代或未取代的咪唑并[5,1-b]噻唑基)乙烯基, 酯。 该化合物对细菌的细菌具有抗菌活性,对革兰氏阳性菌,革兰氏阴性菌和耐药菌具有强力的抗菌活性。 其中X表示CH或N,R 1表示氢原子或氨基保护基,R 2表示氢原子,C 1-6烷基,C 3-7环烷基或羟基 保护基,R3不存在或表示氢原子,形成盐的阳离子或羧基保护基,R4,R5和R6可以相同或不同,各自独立地表示氢原子或C1-6烷基 基团,R 7 +不存在或C 1-6烷基的阳离子,n为0〜1的整数。